Fighting ferroptosis: Protective effects of dexmedetomidine on vital organ injuries

Area of Science:

• Pharmacology
• Cell Biology
• Toxicology

Background:

• Vital organ injury is a major global health concern with limited treatment options.
• Dexmedetomidine (DEX), a selective α2-adrenergic receptor agonist, shows organ-protective properties.
• The precise molecular mechanisms underlying DEX's protective effects, particularly its role in ferroptosis, require further elucidation.

Purpose of the Study:

• To comprehensively review the role of ferroptosis in DEX-mediated protection against vital organ injuries.
• To elucidate the molecular mechanisms by which DEX inhibits ferroptosis.
• To provide a foundation for developing targeted therapies utilizing DEX for organ protection.

Main Methods:

• Systematic review of preclinical in vitro and in vivo studies.
• Analysis of studies investigating DEX's effects on ferroptosis pathways.
• Examination of DEX's impact on iron metabolism and antioxidant systems.

Main Results:

• Ferroptosis is identified as a primary cell death mechanism in vital organ injury.
• DEX demonstrates significant protective effects against organ injury by inhibiting ferroptosis.
• DEX's protective action is primarily linked to the regulation of iron metabolism and antioxidant defense mechanisms.

Conclusions:

• DEX offers a promising therapeutic strategy for mitigating vital organ injury by targeting ferroptosis.
• Understanding DEX's mechanism in regulating iron homeostasis and oxidative stress is key to enhancing its clinical application.
• This review consolidates evidence on DEX and ferroptosis, paving the way for improved organ protection strategies.